Key result
In patients with deep venous thrombosis, a BMI ≥40 was associated with significantly better survival after adjusting for confounders (HR 0.177; 95% CI 0.045-0.691; P=0.013).
Why the study?
Does obesity improve survival in patients with deep venous thrombosis?
Cohort (n=662)
Does obesity improve survival in patients with deep venous thrombosis?
Hazard Ratio: 0.177 (95% CI 0.045–0.691)
p-value: p=0.013
Morbid obesity (BMI ≥40) is paradoxically associated with significantly improved survival in patients with deep venous thrombosis.
No takes yet. Share an insight, caveat, or question.
Should not alter DVT risk stratification; leaves open whether morbid obesity improves survival or reflects confounding.
El‐Menyar et al. (2017) conducted a cohort in Deep venous thrombosis (n=662). Obesity (BMI ≥40) vs. Nonobese patients was evaluated on Survival (HR 0.177, 95% CI 0.045-0.691, p=0.013). In patients with deep venous thrombosis, a BMI ≥40 was associated with significantly better survival after adjusting for confounders (HR 0.177; 95% CI 0.045-0.691; P=0.013).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: